iShares NASDAQ US Biotechnology UCITS ETF (SWX:BTEC)
Switzerland · Delayed Price · Currency is CHF · Price in USD 8.42
-0.17 (-1.92%)
Last updated: Apr 2, 2026, 2:00 PM CET
SWX:BTEC Holdings Information
SWX:BTEC is an equity ETF with a total of 264 individual holdings. The top holdings are Gilead Sciences stock at 7.91%, Amgen at 7.77%, Vertex Pharmaceuticals at 7.70%, Regeneron Pharmaceuticals at 6.53%, and Alnylam Pharmaceuticals at 3.52%.
Total Holdings
264
Top 10 Percentage
44.02%
Asset Class
Equity
ETF Category
Sector Equity Biotechnology
Assets
444.88M
PE Ratio
n/a
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | GILD | Gilead Sciences, Inc. | 7.91% |
| 2 | AMGN | Amgen Inc. | 7.77% |
| 3 | VRTX | Vertex Pharmaceuticals Incorporated | 7.70% |
| 4 | REGN | Regeneron Pharmaceuticals, Inc. | 6.53% |
| 5 | ALNY | Alnylam Pharmaceuticals, Inc. | 3.52% |
| 6 | INSM | Insmed Incorporated | 2.77% |
| 7 | BIIB | Biogen Inc. | 2.31% |
| 8 | UTHR | United Therapeutics Corporation | 2.16% |
| 9 | ARGX | argenx SE | 1.68% |
| 10 | RPRX | Royalty Pharma plc | 1.67% |
| 11 | MRNA | Moderna, Inc. | 1.60% |
| 12 | ROIV | Roivant Sciences Ltd. | 1.59% |
| 13 | ILMN | Illumina, Inc. | 1.55% |
| 14 | RVMD | Revolution Medicines, Inc. | 1.54% |
| 15 | INCY | Incyte Corporation | 1.51% |
| 16 | VTRS | Viatris Inc. | 1.25% |
| 17 | BBIO | BridgeBio Pharma, Inc. | 1.13% |
| 18 | ASND | Ascendis Pharma A/S | 1.13% |
| 19 | SMMT | Summit Therapeutics Inc. | 1.11% |
| 20 | MEDP | Medpace Holdings, Inc. | 1.10% |
| 21 | NBIX | Neurocrine Biosciences, Inc. | 1.08% |
| 22 | IONS | Ionis Pharmaceuticals, Inc. | 1.00% |
| 23 | MDGL | Madrigal Pharmaceuticals, Inc. | 0.97% |
| 24 | SNY | Sanofi | 0.96% |
| 25 | JAZZ | Jazz Pharmaceuticals plc | 0.95% |
As of Apr 1, 2026